Skip to main content
. Author manuscript; available in PMC: 2009 Jul 1.
Published in final edited form as: J Pharmacol Exp Ther. 2008 Apr 25;326(1):286–295. doi: 10.1124/jpet.108.139675

Figure 3.

Figure 3

Inhibition of [125I]RTI-55 binding to hDAT by SoRI-20041 (Panel A) and SoRI-2827 (Panel B). Three concentrations of [125I]RTI-55 were each displaced by 10 concentrations of SoRI-20041 or SoRI-2827. The data, expressed as percentage inhibition, were combined and analyzed for the best-fit estimates of the EMAX and EC50 (See Table 1) as described under Materials and Methods. Each point is the mean ± S.D. (n=4).